Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
Mem. Inst. Oswaldo Cruz
;
109(4): 499-501, 03/07/2014. tab, graf
Artículo
en Inglés
| LILACS
| ID: lil-716309
ABSTRACT
Antimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The global incidence of herpes zoster is approximately 2.5 cases per 1,000 persons per month (or 30 cases per 1,000 persons per year). The estimated incidence of herpes zoster in patients undergoing antimony therapy is higher than previously reported.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Herpes Zóster
/
Antimonio
/
Antiprotozoarios
Tipo de estudio:
Estudio observacional
Límite:
Adulto
/
Anciano
/
Aged80
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Mem. Inst. Oswaldo Cruz
Asunto de la revista:
Medicina Tropical
/
Parasitología
Año:
2014
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Universidade Federal de Mato Grosso/BR
Similares
MEDLINE
...
LILACS
LIS